These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32292091)

  • 1. Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes.
    Tomlinson B; Chan P; Lam CWK
    Expert Rev Endocrinol Metab; 2020 May; 15(3):147-157. PubMed ID: 32292091
    [No Abstract]   [Full Text] [Related]  

  • 2. Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.
    Umpaichitra V; Banerji MA; Castells S
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):853-64. PubMed ID: 15270403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus.
    Vergès B; Duvillard L; Pais de Barros JP; Bouillet B; Baillot-Rudoni S; Rouland A; Sberna AL; Petit JM; Degrace P; Demizieux L
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2198-2206. PubMed ID: 30026275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
    Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
    Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome.
    Tushuizen ME; Pouwels PJ; Bontemps S; Rustemeijer C; Matikainen N; Heine RJ; Taskinen MR; Diamant M
    Atherosclerosis; 2010 Jul; 211(1):308-14. PubMed ID: 20227695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia.
    Chan DC; Pang J; Barrett PH; Sullivan DR; Burnett JR; van Bockxmeer FM; Watts GF
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3732-3739. PubMed ID: 27490922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia.
    Sheu WH; Jeng CY; Lee WJ; Lin SY; Pei D; Chen YT
    Metabolism; 2001 Mar; 50(3):355-9. PubMed ID: 11230791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting serum apolipoprotein B-48 can be a marker of postprandial hyperlipidemia.
    Masuda D; Sakai N; Sugimoto T; Kitazume-Taneike R; Yamashita T; Kawase R; Nakaoka H; Inagaki M; Nakatani K; Yuasa-Kawase M; Tsubakio-Yamamoto K; Ohama T; Nakagawa-Toyama Y; Nishida M; Ishigami M; Masuda Y; Matsuyama A; Komuro I; Yamashita S
    J Atheroscler Thromb; 2011; 18(12):1062-70. PubMed ID: 21946533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls.
    Valdivielso P; Puerta S; Rioja J; Alonso I; Ariza MJ; Sánchez-Chaparro MA; Palacios R; González-Santos P
    Clin Chim Acta; 2010 Mar; 411(5-6):433-7. PubMed ID: 20059992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoB-lipoprotein remnant dyslipidemia and high-fat meal intolerance is associated with markers of cardiometabolic risk in youth with obesity.
    Krysa JA; Ball GDC; Vine DF; Jetha M; Proctor SD
    Pediatr Obes; 2021 May; 16(5):e12745. PubMed ID: 33150705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial hyperlipidemia as a potential residual risk factor.
    Nakamura K; Miyoshi T; Yunoki K; Ito H
    J Cardiol; 2016 Apr; 67(4):335-9. PubMed ID: 26744235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat.
    Matikainen N; Taskinen MR; Stennabb S; Lundbom N; Hakkarainen A; Vaaralahti K; Raivio T
    Eur J Endocrinol; 2012 Mar; 166(3):487-92. PubMed ID: 22190000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease.
    Kumar V; Madhu SV; Singh G; Gambhir JK
    J Assoc Physicians India; 2010 Oct; 58():603-7. PubMed ID: 21510110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 3-month Mediterranean-type diet on postprandial TAG and apolipoprotein B48 in the Medi-RIVAGE cohort.
    Defoort C; Vincent-Baudry S; Lairon D
    Public Health Nutr; 2011 Dec; 14(12A):2302-8. PubMed ID: 22166188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ingestion of a fructose-containing beverage combined with fat cream exacerbates postprandial lipidemia in young healthy women.
    Saito H; Kato M; Yoshida A; Naito M
    J Atheroscler Thromb; 2015; 22(1):85-94. PubMed ID: 25223696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of medications used for the management of diabetes and obesity on postprandial lipid metabolism.
    Eleftheriadou I; Grigoropoulou P; Katsilambros N; Tentolouris N
    Curr Diabetes Rev; 2008 Nov; 4(4):340-56. PubMed ID: 18991602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins.
    Matikainen N; Adiels M; Söderlund S; Stennabb S; Ahola T; Hakkarainen A; Borén J; Taskinen MR
    Obesity (Silver Spring); 2014 Aug; 22(8):1854-9. PubMed ID: 24890344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.
    Pastromas S; Terzi AB; Tousoulis D; Koulouris S
    Int J Cardiol; 2008 May; 126(1):3-12. PubMed ID: 17689745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride.
    Nimitphong H; Phongkitkarun S; Rattarasarn C; Kongsooksai A; Chanprasertyothin S; Bunnag PA; Puavilai G
    Metabolism; 2008 May; 57(5):644-9. PubMed ID: 18442627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text.
    Kolovou GD; Watts GF; Mikhailidis DP; Pérez-Martínez P; Mora S; Bilianou H; Panotopoulos G; Katsiki N; Ooi TC; Lopez-Miranda J; Tybjærg-Hansen A; Tentolouris N; Nordestgaard BG
    Curr Vasc Pharmacol; 2019; 17(5):498-514. PubMed ID: 31060488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.